CareLit · DOI-Nachweis · Pneumologie
Early therapy with bosentan may reverse pulmonary vasculopathy in scleroderma patients
DOI 10.1055/s-0030-1251115
Bibliografische Angaben
Nachweis in CareLit
Autor:innenG Kovacs, X Kqiku, R Maier, E Aberer, M Brodmann, W Graninger, S Scheidl, N Tröster, H Olschewski
ZeitschriftPneumologie
Ausgabe03/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Out-of-proportion pulmonary arterial pressure (PAP) increase during exercise may represent an intermediate stage between normal pulmonary hemodynamics and manifest PAH and might precede PAH in systemic sclerosis (SSc). We hypothesised that bosentan treatment might reverse a trend towards progressive pulmonary vasculopathy in such patients. Patients and methods: SSc patients with a resting PAP30mmHg during exer…
Zitieren
Zitierempfehlung
G Kovacs, X Kqiku, R Maier, E Aberer, M Brodmann, W Graninger, S Scheidl, N Tröster, H Olschewski (2010) Early therapy with bosentan may reverse pulmonary vasculopathy in scleroderma patients. Pneumologie (03). https://doi.org/10.1055/s-0030-1251115
Mit CareLit weiterarbeiten